Breaking News
-
Breaking News | Promotions & Moves
Cytovance Biologics
Bernhard Hampl, Ph.D., has been appointed co-chairman of Cytovance Biologics, Inc.04.25.11
-
Breaking News | Financial Reports
Financial Report: Amgen 1Q11
U.S. product sales in the quarter increased 4% to $2.8 billion.04.21.11
-
Breaking News | Financial Reports
Financial Report: Biogen Idec 1Q11
Growth in the quarter was primarily driven by Tysabri revenues, up 15% to $251 million, and Avonex sales, up 8% to $642 million.04.21.11
-
Breaking News | Financial Reports
Financial Report: Gilead Sciences 1Q11
Sales of Atripla were up 7% to $744.5 million. Sales of Truvada were up 2% to $673.1 million.04.21.11
-
Breaking News | Financial Reports
Financial Report: ICON 1Q11
Gross business wins in the quarter were $329 million, representing a book to bill of 1.43.04.21.11
-
Breaking News | CRO News
ICON, ACRONET Sign Alliance in Japan
ICON and ACRONET Corp. have signed an alliance agreement under which the two companies will collaborate to offer global and Japanese pharmaceutical clients a full range of clinical development capabilities to manage trials both regionally and globally.04.21.11
-
Breaking News | Financial Reports
Financial Report: Elan 1Q11
Tysabri revenues were up 23% to $245.2 million in the quarter, offsetting revenue loss from legacy products including Azactam, Prialt, Maxipime and Skelaxin, which contributed $38.7 million in 1Q10.04.20.11
-
Breaking News | Financial Reports
Financial Report: Abbott 1Q11
Pharmaceutical sales were $3.8 billion in the quarter, up 12%. Humira sales were up 18% to $1.6 billion.04.20.11
-
Breaking News | CRO News
Vince & Assoc. CR Completes Pharmacology Expansion
Vince & Associates Clinical Research has opened its newly expanded, 90-bed Clinical Pharmacology Research Unit.04.20.11
-
Breaking News | Collaborations & Alliances | Validation
Gilead, MicroDose Enter RSV Pact
Gilead Sciences and MicroDose Therapeutx have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of MDT-637, MicroDose’s inhalable small molecule antiviral fusion inhibitor for the treat04.20.11
-
Breaking News | Industry News
Sensient Pharma Expands Production Facility
Sensient Pharmaceutical Coating Systems has completed the expansion of its pharmaceutical coating production facility, more than doubling manufacturing capacity and equipment dedicated to the pharmaceutical and nutraceutical industries.04.20.11
-
Breaking News | Financial Reports
Financial Report: Johnson & Johnson 1Q11
Worldwide Pharmaceutical sales were $6.1 billion in the quarter.04.19.11
-
Breaking News | Financial Reports
Financial Report: Novartis 1Q11
Pharmaceuticals sales were up 7% to $7.8 billion. Diovan sales were down 3% to $1.4 billion.04.19.11
-
Breaking News | Collaborations & Alliances
Doe & Ingalls, BioVectra Expand Distribution Pact
Doe & Ingalls and BioVectra have renewed and expanded their partnership agreement.04.19.11
-
Breaking News | Collaborations & Alliances
Genmab, Seattle Genetics Expand ADC Pact
Genmab and Seattle Genetics have entered into their second antibody-drug conjugate (ADC) research collaboration under which Genmab has rights to use Seattle Genetics’ ADC technology with HuMax-CD74.04.19.11
-
Breaking News | Financial Reports
Financial Report: Lilly 1Q11
Total revenue in the U.S. was $3.1 billion (+1%) primarily due to higher prices, partially offset by lower volume.04.18.11
-
Breaking News | Industry News | Vials
Baxter To Acquire Prism
Baxter International has entered into a definitive agreement to acquire Prism Pharmaceuticals.04.18.11
-
Breaking News | Financial Reports
-
Breaking News | Industry News
Pharmatek Gains DEA Approval
Pharmatek Laboratories has been approved by the U.S. Drug Enforcement Agency (DEA) for the analysis of Schedules I through V controlled substances.04.18.11
-
Breaking News | Collaborations & Alliances
Sanofi-Aventis, Stanford in Research Pact
Sanofi-Aventis has entered a research collaboration through the Stanford University Bio-X program that supports, organizes and facilitates collaborative research projects in the early phases of development.04.18.11
